Elvitegravir
ATC Code
J05AJ02
Elvitegravir
Definition
A modified quinolone antibiotic with activity against human immunodeficiency virus 1. Elvitegravir is an inhibitor of viral integrase and retains activity against integrase mutants that are resistant to Raltegravir.
Also known as 6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, ELVITEGRAVIR, GS 9137, GS-9137, JTK 303, JTK-303 — per NCIT
Also identified as
- ATC J05AJ02 per RXNORM
- NCIT NCIT:C76493 per NCIT
- SCTID 708828000 per RXNORM
- SCTID 714795001 per RXNORM
- UNII 4GDQ854U53 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| HIV infectious disease | may treat | MEDRT · Public domain (U.S. Government work) |